Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director comp.
Acq. announced
Director departure

Nuvation Bio Inc. (NUVB) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/17/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 366,744 options to buy @ $1.64, valued at $601.5k
05/17/2023 4 VERNON W ANTHONY (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 366,744 options to buy @ $1.64, valued at $601.5k
05/17/2023 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 366,744 options to buy @ $1.64, valued at $601.5k
05/17/2023 4 BLICKENSTAFF KIM D (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 366,744 options to buy @ $1.64, valued at $601.5k
05/17/2023 4 Bazemore Robert B (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 366,744 options to buy @ $1.64, valued at $601.5k
03/02/2023 4 Markel Stacy (Chief People Officer) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 500,000 options to buy @ $1.94, valued at $970k
03/02/2023 4 Hung David (President and CEO) has filed a Form 4 on Nuvation Bio Inc.
Txns: Disposed of 368,408 shares @ $0
Granted 2,500,000 options to buy @ $1.94, valued at $4.9M
03/02/2023 4 Hanley David C. (Chief Technical Operations) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 500,000 options to buy @ $1.94, valued at $970k
03/02/2023 4 Fox Jennifer A. (CFO) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 600,000 options to buy @ $1.94, valued at $1.2M
03/02/2023 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 400,000 options to buy @ $1.94, valued at $776k
03/02/2023 4 Liu Dongfang (Chief Medical Officer) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 500,000 options to buy @ $1.94, valued at $970k
03/02/2023 4 Hattersley Gary (Chief Scientific Officer) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 500,000 options to buy @ $1.94, valued at $970k
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/31/2022 4 Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 252,000 options to buy @ $2.93, valued at $738.4k
08/31/2022 4 Markel Stacy (Chief People Officer) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 450,000 options to buy @ $2.93, valued at $1.3M
08/31/2022 4 Liu Dongfang (Chief Medical Officer) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 315,000 options to buy @ $2.93, valued at $923k
08/31/2022 4 Hattersley Gary (Chief Scientific Officer) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 400,000 options to buy @ $2.93, valued at $1.2M
08/31/2022 4 Hanley David C. (Chief Technical Operations) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 450,000 options to buy @ $2.93, valued at $1.3M
08/31/2022 4 Fox Jennifer A. (CFO) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 480,000 options to buy @ $2.93, valued at $1.4M
07/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/28/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/28/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/28/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/28/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/28/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
05/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2022 4 Omega Fund V, L.P. (10% Owner) has filed a Form 4 on Nuvation Bio Inc.
Txns: Sold 2,500,000 shares @ $5.6, valued at $14M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy